Pallavi Sachdev
Company: Eisai
Job title: Executive Director, Translational Medicine
Seminars:
Exploring the Impact of NSD-ISS, New Biological Definition & Staging System on the Parkinson’s Disease Treatment Landscape 11:00 am
Sharing examples of how the revised AD staging criteria has been applied in clinical trials: how will this inform the adoption of PD staging? Highlighting how the NSD-ISS definition will allow for more targeted PD clinical trial designs Comparing and contrasting how the molecular staging of AD and PD will impact the treatment landscapeRead more
day: Pre-Conference Day
Chair’s Closing Remarks & End of Fluid Based Biomarker Seminar Day 2:30 pm
day: Pre-Conference Day
Chair’s Opening Remarks 9:20 am
day: Pre-Conference Day
Panel Discussion: Evaluating the Current Landscape of Plasma-Based Markers of β-Amyloid Pathology in Alzheimer’s Disease & Mapping the Path to Widespread Blood Testing 9:30 am
How will the breakthroughs in blood-based amyloid biomarkers advance precision medicine? What are the opportunities for these β-amyloid assays to be used commercially to inform patient selection? How do we determine the right cut off, based on somebody’s age, gender, or phenotype, to deem a patient amyloid-positive and enrol them? Have there been advancements to…Read more
day: Pre-Conference Day